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Abstract
Background: Autophagy participates in plaque formation and progression; however, its association with foam cells’
fate is unknown. To investigate autophagy features and its effect on the fate of different-stage macrophage foam
cells (FCs). Different-stage FCs were obtained through incubation of THP-1 macrophages (THP-M) with oxidized
low-density lipoprotein LDL (oxLDL, 80 μg/mL) for various durations (0–72 h). Autophagy in THP-1 macrophage
FCs and in apoE−/− mice was regulated by Rapamycin (80 ug/mL) or 3-MA (10 mM). Lipid droplet accumulation,
LC3 I/II, P62 expression level, and autophagic flux were measured. Vascular ultrasound, TUNEL, IHC, and DHE
staining were used to detect the artery plaques in apoE−/− mice.
Results: In early-stage FCs, the amount of autophagosomes gradually increased, and autophagic flux intensity
accelerated, but in mid-late stage FCs, autophagic flux was suppressed. For early stage FCs, treatment with
autophagy activator rapamycin markedly decreased intracellular lipid content and prevented them from
transforming into foam cells, while the autophagy inhibitor 3-MA considerably increased the intracellular
lipid-droplet accumulation. During the process of foam cell development, upregulating autophagy not only
reduced intracellular lipid-droplet accumulation, but also inhibited cell apoptosis through clearing dysfunctional
mitochondria and lowering intracellular ROS level. The in vivo experiments produced consistent results that
rapamycin administration in apoE−/− mice reduced the death rate of macrophages and delayed plaque
progression.
Conclusions: The fate of macrophage FCs was associated with autophagy. Early autophagy enhancement
inhibits the formation and progression of macrophage FCs and prevents atherosclerosis.
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Background
Autophagy is an evolutionarily conserved mechanism
and the only physiological self-protective process through
which organisms remove damaged or unwanted intracel-
lular materials, including protein aggregates, lipid drop-
lets, dysfunctional mitochondria, and other damaged
intracellular organelles. The autophagic process is classic-
ally considered to be a pathway contributing to cellular
homeostasis and adaptation to stress [1, 2]. Under the
action of stress factors, basal autophagy may act as a pro-
survival mechanism in an adverse environment [3, 4].
However, dysfunctional autophagy is associated with hu-
man disease. Defects in autophagy have been implicated
in the pathogenesis of cancers, heart failure, cancer,
neurodegeneration [5], and inflammatory diseases [6–8].
However, little is known about the role of autophagy in
atherosclerosis.
A limited number of clinical studies have shown that
autophagic markers are co-localized with macrophages
in atherosclerotic plaques, and autophagy is impaired in
the advanced stages of atherosclerosis; its deficiency
induced lethal accumulation of cholesterol crystals and
promoted atherosclerosis [9–11]. Stent-based delivery of
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the mTOR inhibitor everolimus promotes a stable plaque
phenotype. However, the direct evidence indicating the
role of autophagy is insufficient. Monocytes/macrophages
are the predominant cell type expressing autophagy
markers in the plaque [12]. Several basic examinations
also revealed that mice with a macrophage-specific dele-
tion of the essential autophagy gene Atg5 developed
plaques with increased apoptosis and oxidative stress and
exhibited enhanced plaque necrosis [13], suggesting that
autophagy is involved in AS pathology. Nevertheless, little
is known about the regulation and mechanism associated
with autophagy in the pathogenesis of atherosclerosis
[10, 14, 15]. There are still some important questions to
be elucidated, including changes in autophagy with AS
progression, critical time points for correcting dysfunc-
tional autophagy, and the effective regulation of autoph-
agy to achieve a positive effect in inhibiting atheroma
progression.
The present study was designed to address these issues
using oxidative low-density lipoproteins (ox-LDL)-treated
THP-1 macrophages and high-fat–fed Apo E −/− mice.
We investigated the characteristics of autophagy at differ-
ent stages of the development of THP-1 macrophage
(THP-M)-derived foam cells and explored its mechanism
of action and effect on middle-late foam cell viability.
Mechanistically, this process, in part, involves mitochon-
drial oxidative stress and cell apoptosis. In Apo E −/−
mice, the suitable upregulation of autophagy delays the
progress of atherosclerotic plaques.
Methods
Culture and differentiation of THP-1-derived
macrophages
Ox-LDL-treated THP-1 macrophage is a commonly used
model in the studies on autophagy associated with
atherosclerosis. Initially, THP-1 cell (ATCC, Manassas,
VA, USA) was cultured in RPMI-1640 medium (Invitro-
gen, San Diego, CA, USA) supplemented with 20 U/mL
penicillin (Invitrogen), 20 μg/mL streptomycin (Invitro-
gen), and 10 % fetal bovine serum (FBS) (Lonza, Walkers-
ville, MD, USA). All cells were cultured at 37 °C in a 5 %
CO2 environment, and the cellular medium was changed
every 2–3 days. Cells were passaged upon reaching 80 %
confluence, and all experiments were performed using
cells at passage eight or lower. Then, to induce FC differ-
entiation, THP-1 cells were incubated with 10−7 M
phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich)
for 48 h, followed by incubation with 80 μg/mL oxLDL
(Intracel Resources, Frederick, MD, USA) for 0, 6, 24, 48,
and 72 h to form foam cells at differential stages.
Oil red staining
To identify the lipid acumination at different stages of
foam cell formation, after incubation with oxLDL for 0,
6, 24, 48, or 72 h, THP-M were stained with Oil Red
(Sigma-Aldrich, MO, USA) for 10 min at RT. The Oil
Red staining allowed for visualization and imaging of FC
containing intracellular lipid droplets via a Leika micro-
scope (Nikon Inc., Melville, NY, USA) at an objective
magnification of 20×. The cells were photographed with a
Coolsnap ES camera (Photometrics, Tucson, AZ, USA),
using Simple PCI image capture software (Hamamatsu
Corporation, Sewickley, PA, USA).
MTT assay
Cell viability was measured by the MTT assay (M5655,
Sigma-Aldrich, Inc., Saint Louis, MO, USA), based on
the MTT conversion into formazan crystals via the ac-
tion of mitochondrial dehydrogenases. Briefly, THP-M-
derived foam cells were plated at a density of 2.5 × 104
cells/cm2 in 96-well plates. After the treatment, the cul-
ture medium was replaced with 200 μL of MTT solu-
tion (5 mg/mL stock solution in PBS, diluted with
culture medium to the final concentration 0.5 mg/mL).
After 4-h incubation at 37 °C, this solution was re-
moved, and the produced formazan was solubilized in
150 μL dimethyl sulfoxide (DMSO). The absorbance
was measured at 570 nm through an automated micro-
plate reader (Tecan Infinite 200 pro microplate reader,
Männedorf, Switzerland). Cell viability was calculated
by comparing the results to those of the control cells,
which were considered 100 % viable.
Flow cytometry
Detection of apoptosis and mitochondrial superoxide
production was performed as previously described (17).
Samples were analyzed using a BD FACSCanto II flow
cytometer (BD Biosciences, CA, USA). For Annexin V-
FITC/PI staining, the maximum FITC excitation wave-
length/emission wavelength was 488 nm/525 nm, and
the maximum PI excitation wavelength/emission wave-
length was 535 nm/615 nm, respectively. A number of
10,000 events were collected for each sample. The Cell-
Quest software (Becton Dickinson, San Jose, CA, USA)
was used to analyze the data obtained.
mRFP-GFP-LC3 plasmid construction and transfection
Microtubule-associated protein light chain 3 (LC3) is an
ubiquitin-like protein that binds to autophagosomes
(AVs). Typically, mammalian cells are transfected with
GFP-tagged LC3 to track and follow the fate of AVs in
the cell and to measure the autophagic flux. Here, we
used an adenovirus (Ad-LC3-GFP-mRFP) expressing the
GFP and mRFP fluorescent proteins for marking and
tracking LC3 (HANBIO, Shanghai, China). In brief, 1640
medium (containing 10 % FBS) was employed to culture
THP-1 cells which were incubated with the Ad-LC3-
GFP-mRFP adenovirus for two hours to be infected.
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Then, the culture medium was replaced and the incuba-
tion continued for 36 h. Counting of autophagosomes and
autolysosomes was performed on a Thermo Scientific Cel-
lomics ArrayScan HCS reader (Thermo Fisher Scientific,
Pittsburgh, PA, USA) (20x objective) using the Spot de-
tector V3 Cellomics Bioapplication (Cellomics, USA.)
GFP and RFP vesicles were identified on separate second-
ary channels by FITC- and Texas Red-associated filters,
respectively, depending upon size, shape, and intensity
thresholding. The mean number of vesicles per cell
(object) was calculated by the ArrayScan software, as
the total number of vesicles per field was divided by
the total number of objects per field. One thousand
cells were counted per coverslip, and the analysis was
conducted on triplicate samples at least twice. The yel-
low spots and red spots after overlapping represented
autophagosomes and autolysosomes, respectively. Through
counting the different color spots, we determined the pres-
ence of autophagy in the different groups.
Measurement of mitochondria oxidative stress
Mitochondria-derived superoxide anion in THP-M cells
of different stages was determined quantitatively by an
ELISA method based on Mito SOX (Molecular Probes),
according to the manufacturer’s protocol. Superoxide
anion generation was also established semi-quantitatively
by fluorescence intensity as detected by the Image-Pro
Plus software in conjunction with a Leica Confocal
microscope.
Western blotting
Aliquots of 20 mg of protein extracts from human THP-1
macrophages were separated by 10 % sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and subjected to immunoblotting with the following anti-
bodies LC3B (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and P62, GAPDH (1:1000) [16–19]. The densities of
the bands were measured using a Densitograph System
(Ez-Capture II and CS Analyzer 3.0, ATTO, Tokyo, Japan),
and the ratio to GAPDH was calculated.
Animal experiments
The animal experiments were approved by the Institu-
tional Animal Care and Use Committee of Fuwai Hospital
(Permission No. 2013-6-40-GZR). A total of 24 8-week-
old male spontaneously hyperlipidemic ApoE−/− mice
were purchased from the Institute of Laboratory Animal
Sciences, Chinese Academy of Medical Sciences (CAMS)
& Peking Union Medical College (PUMC) and fed with a
high-fat rodent diet containing 21 % fat from lard and
supplemented with 0.15 % (wt/wt) cholesterol (Special
Diets Services) until 16 weeks of age (18). At that age, 24
mice were allocated by body weight and plasma total
cholesterol levels into three groups (10 animals/group):
the vehicle group, the Rapa group, and the 3-MA group.
The animals were administered either the vehicle or the
respective drug by i.p. route once a day for 6 weeks.
Intravascular ultrasonic imaging
Mice were anesthetized using 10 % chloral hydrate (3 mL/
100 g). Echocardiography was performed with a Vevo2100
ultrasound system (VisualSonics Inc., Toronto, Canada)
and a MS400 transducer. Intravascular ultrasonic imaging
was conducted to compare the effect of autophagy on
plaque formation. Echocardiograms were interpreted by
two separate cardiologists who were blinded to the animal
groups.
Histologic examination of atherosclerosis
At 24 weeks of age, ApoE−/− mice were anesthetized
with diethyl ether. The aortic root was carefully excised
and fixed with 4 % formaldehyde and 10 % sucrose. The
sections were stained with hematoxylin-eosin (HE) and
oil red O to measure the total lesion area. The degree of
intimal thickening was evaluated as previously described
(14). Briefly, the lesion area of the intima and the lu-
minal circumference of the media in the oil red-stained
section were measured by an image analyzer. The in-
timal thickness (mm) was then calculated by dividing
the intimal lesion area by the luminal circumference of
the media. The cellular components of the atheroscler-
otic lesion in the thoracic aorta lesion were examined
immunohistochemically by the streptoavidin method
(LSAB Kit, Dako Japan Co, Ltd, Tokyo, Japan) using an
anti-macrophage antibody (MOMA-2) as the primary
antibody and a biotin-labeled anti-mouse IgG antibody
and a biotin-labeled anti-sheep IgG antibody (MBL Co,
Ltd, Nagoya, Japan) as the secondary antibodies, respect-
ively. The following parameters were measured: plaque
cross-sectional area, media cross-sectional area, percent-
age of occlusion of the lumen by plaque, the number of
buried fibrous caps, current fibrous cap thickness, and
percentage of lipid content of the plaque. An assessment
of the oxidative stress in aortic root frozen-tissue sec-
tions was performed by fluorescence microscopy of
dihydroethidium (DHE)-stained sections as previously
described [16].
Statistical analysis
Statistical significance was calculated via the unpaired
Student’s t-test between two groups and 1-way ANOVA,
followed by the Bonferroni’s post-hoc test among multiple
groups by the Statview J-5.0 software (SAS Institute, Cary,
NC, USA). A value of P < 0.05 was considered to be statis-
tically significant. All values were expressed as the mean
± standard error of the mean (SEM).
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Results
Assessment of lipid content and cell viability during the
course of macrophage-derived foam cells formation and
progress
The qualitative observations via the Oil Red staining re-
vealed the presence of a gradually increasing accumulation
of larger-sized intracellular lipid droplets within the cyto-
plasm of the oxLDL-treated THP-1 macrophage (Fig. 1a).
At the twenty-fourth hour, the mean lipid content per cell
(52.0 ± 1.8 %) was significantly elevated compared to that
of the control group (9.4 ± 0.9 %) (P < 0.05) (Fig. 1b), indi-
cating that THP-1 macrophage derived foam cells had
formed. However, after the 24 h, cell viability was trending
down, which was an opposite tendency compared with
that of intracellular lipid accumulation (Fig. 1c).
Assessment of autophagy changing manner during
macrophage-derived foam cell formation and progress
Autophagy is dynamic and encompasses autophagosome
formation, cargo sequestration, and eventual lysosomal
fusion/degradation occurring in rapid succession. To
explore the involvement and manner of action of au-
tophagy in the process of foam cell formation, we used
Western blotting and mRFP-GFP-LC3 adenovirus infec-
tion to determine the amounts of autophagosomes and
autophagic flux at different stages of foam cell progres-
sion, respectively.
Western blot results demonstrated that the conversion
of LC3-I to LC3-II in THP-M increased gradually within
the first 24 h, which was consistent with the presence of
defensive autophagy. Notably, P62 expression levels
tended to attenuate with incubation time (Fig. 2a, b).
However, after the treatment with oxLDL for 48 h, LC3-
II levels significantly decreased from 30.2 ± 2.3 % (24 h)
to 12.1 ± 1.5 % (48 h) (black column, P < 0.05), whereas
there was no obvious change in the level of P62 in the
high-lipid-accumulating foam cells compared with that
at 24 h (light grey column, 13.2 ± 1.3 % vs 12.6 ± 1.2 %).
Because GFP fluorescent protein is sensitive to acid,
weakening of GFP signal may indicate that a lysosome
has fused with an autophagosome to form an autolyso-
some, leading to GFP fluorescence quenching. As shown
in Fig. 2c and d, in the first 24 h, the number of autoly-
sosomes per cell increased from 3 dots (baseline) to 21
dots (the highest at the 24-h time point), and after 24 h,
it decreased gradually to 4–5 dots per cell (at 72 h).
These results showed that at the early stage, the amount
of autophagosomes was increased, and autophagic flux
intensity was accelerated, but at the mid-late stage of
foam cell progress, autophagic flux was suppressed.
Autophagy affects the fate of macrophage-derived foam
cells
Many studies have provided evidence that autophago-
somes exist in different stages of AS, indicating the
involvement of autophagy in AS occurrence and devel-
opment. However, the feasibility of autophagy as the
target of treating AS is debated. One of the reasons
may be that the effects of the same agent on different
stages of foam cells formation are significantly different
[17]. Therefore, according to the above results, we re-
spectively selected early 6 and 48 h as regulatory “Key
points” of foam cells life cycle to explore the effect of
autophagy on the fate of THP-M-derived foam cells.
During the process of foam cell formation, co-culturing
THP-M with oxLDL for 6 h in the presence of autophagy
activator rapamycin (80 ug/mL) markedly decreased intra-
cellular lipid content, while the autophagy inhibitor 3-MA
(10 mM) considerably increased the intracellular lipid
content (upper panel in Fig. 3a, b). Furthermore, Western
Fig. 1 OxLDL-induced lipid accumulation and cell viability changes in human THP 1-derived macrophages. THP-1 macrophages were incubated
with 80 ug/mL oxLDL for 0, 6, 24, 48, and 72 h. The intracellular lipid accumulation was determined by oil red staining and quantified with IPP
software (a); (b) During the courses of foam cells formation and progress, cell viability was measured with MTT staining; (c) The data are expressed
as means ± SD from at least 3 independent experiments. *P < 0.05 vs. 0 h. scale bars = 25 um
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blot results demonstrated that 80 μg/mL of rapamycin
successfully upregulated the conversion of LC3I to
LC3II, while P62 levels in the cytoplasm decreased sig-
nificantly compared with that of the control. The applica-
tion of 3-MA at 10 mM effectively inhibited autophagic
process (Fig. 3c), which was consistent with previous
studies [18, 19].
During the process of foam cell progress, THP-M was
co-cultured with oxLDL for 48 h. As shown in Fig. 3, Rapa
not only reduced significantly the lipid content in the
cytoplasm (downside panel in Fig. 3a, b), but also in-
creased the viability of mid-late-THP-M derived foam
cells (Fig. 3d, e). To determine if the inhibition of macro-
phage autophagy affected the fate of mid-late THP-M-
derived foam cells, we treated THP-M with autophagy in-
hibitor 3-MA. Not only was the lipid content increased,
but also cell viability was significantly impaired, suggesting
the fate of THP-M-derived foam cells was associated with
autophagy.
Autophagy influenced atherosclerotic lesion area and
stability
Atherosclerotic lesions in the apoE−/− mice aorta were
examined by an intravascular ultrasonic imaging system
eight weeks following treatment with rapa, 3-MA or 0.9 %
normal saline (Vehicle control). The results showed that
the atherosclerotic lesions in the abdominal aorta of the
control group were much larger than those of the Rapa
group, but were significantly smaller than those in the 3-
MA treated group (Fig. 4a). After 16 weeks of the treat-
ment, mice were euthanized. The atherosclerotic lesions
were assayed by aortic root Oil Red O staining techniques
(Fig.4b). These observations are supported by a recent
report demonstrating a role for autophagy in foam cell
Fig. 2 Assessment of autophagy in different stages of THP-M-derived foam cell formation. a Western blot analysis of p62 and LC3II/LC3I after
THP-M incubation with oxLDL for 0 h, 6 h, 24 h, 48 h, and 72 h. The ratios of the mean grayscale of LC3I, LC3II, and P62 to GAPDH among groups
are shown in (b); (c) Ad-LC3-GFP-mRFP infection measure autophagic flux intensity quantitative analysis; (d) the amounts of autolysosomes (red)
and autophagosomes (yellow). The data are presented as mean ± SEM. *,§P < 0.05 vs control group
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formation [20]. The atherosclerotic lesion area was
evaluated as a ratio to the area of the whole aorta. The
aortic root lesion area was reduced significantly by
rapamycin (P < 0.05). There was a statistically signifi-
cant difference between Rapa and 3-MA groups con-
cerning the atherosclerotic lesion area. Our findings
also supported the notion that autophagy was substan-
tially impaired in the advanced stages of atherosclerosis,
and autophagy deficiency promoted atherosclerosis.
To determine which cells in atherosclerotic plaques
express autophagy markers, we characterized ApoE−/−
atherosclerotic aortic roots by immunofluorescence. The
autophagy markers LC3 (Fig. 4c) were concurrently
imaged with MOMA-2 (an antibody that recognizes
monocyte-macrophages). These results indicated that
monocytes/macrophages were the predominant cell type
expressing autophagy markers in the plaque and were
likely responsible for progressive autophagy deficiency.
The TUNEL assay (Fig. 4d) showed that the apoptotic
cell number in the rapa-treated group was considerably
lower than that in the control group, indicating that
Rapa can prevent mid-staged AS from plaque progres-
sion and enhance the stability of plaques.
Potential mediators of autophagy biological effect
One of the proposed mechanisms for foam cell apoptosis
has been the presence of reactive oxygen species (ROS)
[21, 22]. Thus, we looked for signatures of ROS activation
Fig. 3 Effect of autophagy on the process of THP-M derived foam cells formation and progress. a Intracellular lipid content measurement by using oil
red staining after incubation with oxLDL for 6 h (upper panel) or 48 h (downside panel) under conditions of autophagy activation (Rapa) or inhibition
(3-MA); (b) Quantitative analysis of oil red positive area by using IPP software. The bars represent the mean of three independent experiments.
* P < 0.05 vs. control group; (c) Western blot analysis for the regulatory effect of Rapa or 3-MA on autophagy specific molecules; (d) The cell
viability was detected by an MTT assay. The results showed that the Rapa treatment improved the viability of mid-late stages foam cells in the
48-h group, but exerted no effect on the foam cells that were cocultured with oxLDL for 6 h; (e) The AV-PI two-color dot plot for cell viability
to further test the effect of rapa on mid-late staged foam cells. The values are the means ± SD of 3 separate experiments; *P < 0.05 vs. control group
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Fig. 4 (See legend on next page.)
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in the THP-M-derived foam cells and atherosclerotic pla-
ques. To understand the mechanistic basis of autophagy
in the progress of atherosclerosis, we examined intra-
cellular ROS production under upregulated autophagy
(Rapa-treated group) or downregulated autophagy con-
ditions (3-MA-treated group). As depicted in Fig. 5a,
the ROS level in the Rapa group was suppressed to
54 %. There was a significant increase of the mitochondria-
derived superoxide anion levels in 3-MA groups (P < 0.05),
which was consistent with that in the autophagy specific si-
lencer (Atg 5-siRNA) treated group (Additional file 1: Fig-
ure S1). All of the above data indicated that maintenance
of autophagy activity could largely prevent mitochondria-
derived superoxide production. Dihydroethidium (DHE)
staining was used to detect ROS production of atheroscler-
otic aortic roots since DHE can react with ROS and form
ETH that binds to DNA and produces a red fluorescence
signal. The mean fluorescence density in the Rapa-treated
group was significantly lower than that in the vehicle con-
trol group, but there was a marked rise in the amount of 3-
MA-treated mouse plaques (Fig. 5b).
Discussion
In the present study, for the first time, we clarified the
changing pattern and function of autophagy in the de-
velopment and progress of macrophage-derived foam
cells and validated the hypothesis that in middle-late
foam cells, autophagy was restrained, intracellular accu-
mulation of lipid droplets and mitochondria clearance
impaired, and a large number of reactive oxygen species
generated. Cell viability decreased, which may be the
most important factor that contributed to plaque pro-
gress and instability, autophagy may be a potential target
for AS treatment. Therefore, our study has discovered a
novel perspective to understand the mechanism of plaque
stability and provides a clue for developing comprehensive
methods for diagnosis and treatment of AS.
Autophagy is dynamic and has also been shown to be
directly involved in lipid homeostasis [23, 24]. This type
of autophagy, called lipophagy, was first found in the
liver and has now become a subject of intense research
interest with potentially profound implications for the
treatment of the diseases associated with dyslipidemias,
such as diabetes and atherosclerosis [25, 26]. In this exam-
ination, to clarify the changing pattern and function of au-
tophagy in AS, THP-1 macrophage was induced with ox-
LDL (80 μg/mL) into different stages of foam cell models.
When cocultured with ox-LDL for 6–72 h, THP-M cell
morphology and lipid content were in line with the char-
acteristics of foam cells at the early stage, middle stage, or
late stage. After 48 h, irreversible death occurred in a large
number of foam cells. Therefore, in this study, 6 or 48 h
(See figure on previous page.)
Fig. 4 Autophagy influences atherosclerogenesis. a Atherosclerotic lesions (red arrows) in the aorta were examined after 8 weeks of treatment by
an intravascular ultrasonic imaging system; (b) Atherosclerotic lesion formation (blue arrows) under Oil Red O staining in ApoE−/− mice at
16 weeks after administration; (c) Representative images and morphometric analysis for the macrophages specific marker MOMA2 (red) and
autophagy specific marker LC3II (green) staining from the aortic root; (d) TUNEL assay and DAPI staining. Green spots represent apoptotic bodies
and blue spots represent cell nuclei; (e) Statistical data of atherosclerotic lesion area in the aortic root; (f) Statistical data of TUNEL positive cells.
Apoptosis rate was calculated based on the results of the TUNEL assay. The pictures are representative of multiple sections of aortas from
different groups of mice (at least 5 in each group);*P < 0.05 when compared with Vehicle group; scale bar = 80 um. Values are the mean ± SD of
3–5 separate experiments; *P < 0.05 vs. control group
Fig. 5 Reactive Oxygen Species is a potential mediator for the
protective effect of autophagy. a Measurement of the ROS production
in THP-1 macrophage foam cells of different groups using flow
cytometry; (b) Confocal reflectance microscopy of formaldehyde-fixed
frozen-section aortic roots from Western diet-fed control, rapa, and
3-MA treated ApoE−/− mice. Reflectance images for a representative
area of the aortic root are shown in B-i, −ii, and −iii, and quantified by
using the IPP image analysis software. Values are given as mean ±
standard deviation of the mean (n = 3). *P < 0.05 versus the control
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were selected as optimal time points to regulate autophagy
and investigate its effect.
It is well known that the autophagy process includes
autophagosome formation, cargo sequestration, and
eventual lysosomal fusion/degradation occurring in rapid
succession. Autophagosome-lysosomal fusion is the es-
sential step. LC3-II is a relatively sensitive biochemical
marker of autophagy. Ad-LC3-GFP-mRFP is a reporter
system. LC3 is distributed in the cytoplasm under nor-
mal conditions (LC3-I), but when autophagy is induced,
LC3-I is modified to become LC3-II, which is integrated
into the autophagosome membrane [26]. In the early-
staged foam cells, with prolonged oxLDL incubation
time, autophagosomes continued to increase, and the
autophagic flux intensity was gradually enhanced, char-
acterized by an increased proportion of LC3II/I and per-
centage of mRFP-positive cells. When THP- M cells
were incubated with oxLDL and Rapa for 6 h, the oil red
staining assay results showed that the lipid deposition in
cells was limited, and while intracellular autophagosome
and autophagy-lysosome quantity increased gradually,
the cell membrane remained intact. When oxLDL and
THP-M interaction lasted beyond 6 h, autophagy was
restrained; the deposition of lipid droplets in cells in-
creased obviously, and the rapa treatment at this stage
not only corrected the dysfunctional autophagy and de-
creased the formation rate of foam cells.
Komatsu et al. found that homeostatic levels of p62 con-
trol cytoplasmic inclusion body formation in autophagy
deficient mice. p62, a chaperone that shuttles intracellular
protein aggregates into autophagosomes for degradation,
has emerged as a useful marker of autophagic status
[27–30]. Since the entire p62/SQSTM1-protein aggre-
gate complex is degraded after engulfment by the
autolysosome, p62 level is inversely correlated with
autophagic flux, i.e., the increases of p62 level indicate
defective autophagy [29, 30]. Our results also showed
that P62 level decreased at the early stage of foam cell
formation. Published evidence supports this possibility.
The cells in atherosclerotic plaques develop progressive
lysosomal dysfunction with features resembling a
lysosomal storage disease [31]. The accumulation of
unhydrolyzed cholesteryl esters and trapped/poorly
translocated free cholesterol in lysosomes has been
described in macrophage foam cells [32–37]. These
unmetabolized substituents may impair the lysosomal
degradation capacity of lipases and other enzymes, includ-
ing proteases. Our observation that p62 accumulates in
the advanced atherosclerotic plaques is consistent with
this concept and verify that autophagy is inhibited in ad-
vanced plaques.
The general consensus on the function of autophagy is
that in contrast to basal autophagy, the excessive stimula-
tion of autophagy may cause autophagic cell death. This is
logical since both autophagy and cell death may be acti-
vated in response to similar stress conditions [38, 39].
Therefore, the proper regulation of autophagy at the right
time point is important. Facing the inhibited autophagy in
advanced atherosclerotic plaque, an important question
exists whether it is feasible to consider autophagy as an
intervention target?
In this study, we fed Apo E −/− mice (known to be
susceptible to atherosclerosis) with a Western diet for
16 weeks (middle phase of spontaneous AS) and treated
them with an autophagy stimulator (Rapa) or autophagy
inhibitor (3-MA) for 8 weeks. Then, assessments were
performed of plaque area/stability, the types of inflam-
matory cells infiltration, ROS levels, and cell viability in
the aortic roots of mice in the different groups.
According to our results, upregulation of autophagy to
its normal level did decrease the apoptosis rate in mid-
late phase THP-M foam cells and suppress the atheroma
progression. However, what is the nature of this action?
We found that the autophagic removal of damaged
mitochondria (also called mitophagy) was enhanced,
and, in turn, reduced reactive oxygen species (ROS) pro-
duction. It has been demonstrated that release of ROS
and DNA from damaged mitochondria can activate
inflammasomes, a process that contribute to plaque for-
mation and progression [22, 40]. Therefore, the possible
mechanism of the protective effect of rapa is through
upregulation of autophagy and decrease of mitochon-
drial ROS. On the other hand, the observation that
plaques treated with the autophagy inhibitor 3-MA in-
creased the levels of markers of protein oxidation and
superoxide production lends credence to this possibility.
There were several limitations of this study. This work
was focused on studying the function of autophagy on
the fate of macrophage-derived foam cells and explor-
ation of the most relevant intervention time. Although
we have used the respective autophagy agonists and in-
hibitors to observe the effect of autophagy on the foam
cell development in Ox-LDL-treated THP-1 macro-
phages or the progress of atherosclerotic plaques in high
fat diet Apo E −/− mice, we did not use foam cells
derived from vascular smooth muscle cells, which are
also important for atherosclerosis plaque formation and
maintenance of the stability of atherosclerotic lesions. In
addition, if macrophage-specific autophagy defects in
mice can be used to repeat and further develop the pre-
liminary findings of this study in the future, the results
would be more persuasive and convincing.
Conclusions
The fate of macrophage FCs was associated with autoph-
agy. Autophagy might be a promising intervention target
for AS treatment.
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Additional file
Additional file 1: Figure S1. Atg 5-siRNA had an enhancing effect on
the production of mtROS similar to that of 3-MA. (A) Measurement of the
mtROS production in THP-1 macrophage foam cells of different groups
using flow cytometry. (B) Confirming the influence of Atg 5-siRNA on the
expression of Atg 5 using Western blotting. Scambled siRNA is the negative
control siRNA with the same nucleotide composition as Atg5 siRNA but
which lacks significant sequence homology with the genome. (TIF 874 kb)
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